Course of arterial hypertension during breast cancer chemotherapy with anthracyclines
Aim. To study the characteristics of the course of arterial hypertension (AH) and subclinical cardiac damage during breast cancer chemotherapy with doxorubicin.Materials and methods. The study included a total of 27 women with breast cancer (BC) and a history of controlled hypertension who were to r...
Saved in:
| Main Authors: | E. N. Berezikova, S. N. Shilov, A. A. Popova, M. N. Neupokoeva, A. T. Teplyakov, E. V. Grakova, K. V. Kopeva, V. V. Kalyuzhin, A. Yu. Yushin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Siberian State Medical University (Tomsk)
2024-10-01
|
| Series: | Бюллетень сибирской медицины |
| Subjects: | |
| Online Access: | https://bulletin.ssmu.ru/jour/article/view/5732 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The cardiovascular system in patients with anthracycline cardiomiopathy
by: Alexandr T. Teplyakov, et al.
Published: (2017-10-01) -
The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy
by: A. T. Teplyakov, et al.
Published: (2019-03-01) -
Prognostic value of humoral markers in patients with anthracycline-related cardiac dysfunction
by: E. V. Grakova, et al.
Published: (2023-10-01) -
Relationship between Chemotherapy and Atrial Fibrillation: Clinical Case
by: A. A. Avagimyan, et al.
Published: (2021-11-01) -
Pharmacogenetics in treatment of anthracycline-induced cardiotoxicity in women without prior cardiovascular diseases
by: E. V. Grakova, et al.
Published: (2023-01-01)